United Therapeutics
UTHR
#1085
Rank
S$27.66 B
Marketcap
S$611.66
Share price
-0.33%
Change (1 day)
23.20%
Change (1 year)

United Therapeutics (UTHR) - P/B ratio

P/B ratio as of January 2026 : 3.27

According to United Therapeutics's latest financial reports the company has a price-to-book ratio of 6.89381.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

United Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-313.4839.56%
2024-12-312.4944.43%
2023-12-311.73-34.66%
2022-12-312.647.49%
2021-12-312.4623.72%
2020-12-311.9942.91%
2019-12-311.39-17.77%
2018-12-311.69-43.91%
2017-12-313.01-7.74%
2016-12-313.27-27.08%
2015-12-314.48-7.05%
2014-12-314.8210.33%
2013-12-314.3778.48%
2012-12-312.45-14.81%
2011-12-312.87-30.21%
2010-12-314.12-5.83%
2009-12-314.3767.09%
2008-12-312.62-64.38%
2007-12-317.3428.71%
2006-12-315.71-2.6%
2005-12-315.8610.87%
2004-12-315.2881.27%
2003-12-312.9243.21%
2002-12-312.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Eli Lilly
LLY
40.5 1,137.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
7.04 115.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.14 56.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
1.54-53.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.40-57.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-14.9-554.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.76 45.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
-18.1-653.65%๐Ÿ‡บ๐Ÿ‡ธ USA